Monthly Archives: March 2024

Community Pharmacy England’s third annual Pressures Survey is underway, and many pharmacy owners and teams have been responding. Thank you to everyone who has already responded to the survey during this busy time; we very much appreciate your support. However, we’re keen to hear from even more voices across the sector. Every contribution is important [...]

The post Pharmacy Pressures Survey 2024: Your input is vital appeared first on Community Pharmacy England.

Community Pharmacy England, in collaboration with Kingston University and the Community Pharmacy IT Group (CP ITG), has launched a short survey to gather feedback on electronic health records and their future needs, such as the Summary Care Record  (SCR) and the National Care Record Service (NCRS). To participate in the survey, please click on the [...]

The post Share your views: Electronic health records appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/09 Date issued: 19 March 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Oestrogel Pump-Pack 750 micrograms/actuation Gel (estradiol) (Besins Healthcare (UK) Ltd) PL 28397/0002 SNOMED Code: 3414911000001105 Batch No Expiry Date Pack Size First Distributed 74800 31/07/2026 1 06/11/2023 74830 31/08/2026 [...]

The post MHRA Class 3 Medicines Recall: Oestrogel Pump-Pack 750 micrograms/actuation Gel (estradiol) (Besins Healthcare (UK) Ltd) appeared first on Community Pharmacy England.

Pharmacy owners are reminded that from 1st April 2024,  they must have an otoscope available, and all clinical pathways must be provided in bricks and mortar* pharmacies registered to provide the Pharmacy First service. This deadline was highlighted in the NHS England letter announcing the Pharmacy First service, which advised that pharmacy owners could start [...]

The post Pharmacy First: Requirement to have an otoscope from 1st April appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre-filled pen Dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection in a prefilled pen Liraglutide (Victoza®) 6mg/ml solution for injection in a pre-filled pen. MSN/2024/031 Tier 3 – [...]

The post Medicine Supply Notification: Supply issues with multiple GLP-1 RA products appeared first on Community Pharmacy England.